» Articles » PMID: 35406433

Sphingosine 1-Phosphate Receptor 5 (S1P5) Deficiency Promotes Proliferation and Immortalization of Mouse Embryonic Fibroblasts

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Apr 12
PMID 35406433
Authors
Affiliations
Soon will be listed here.
Abstract

Sphingosine 1-phosphate (S1P), a bioactive lipid, interacts with five widely expressed G protein-coupled receptors (S1P1-5), regulating a variety of downstream signaling pathways with overlapping but also opposing functions. To date, data regarding the role of S1P5 in cell proliferation are ambiguous, and its role in controlling the growth of untransformed cells remains to be fully elucidated. In this study, we examined the effects of S1P5 deficiency on mouse embryonic fibroblasts (MEFs). Our results indicate that lack of S1P5 expression profoundly affects cell morphology and proliferation. First, S1P5 deficiency reduces cellular senescence and promotes MEF immortalization. Second, it decreases cell size and leads to cell elongation, which is accompanied by decreased cell spreading and migration. Third, it increases proliferation rate, a phenotype rescued by the reintroduction of exogenous S1P5. Mechanistically, S1P5 promotes the activation of FAK, controlling cell spreading and adhesion while the anti-proliferative function of the S1P/S1P5 signaling is associated with reduced nuclear accumulation of activated ERK. Our results suggest that S1P5 opposes the growth-promoting function of S1P1-3 through spatial control of ERK activation and provides new insights into the anti-proliferative function of S1P5.

Citing Articles

Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets.

Rufail M, Bassi R, Giussani P Int J Mol Sci. 2025; 26(3).

PMID: 39940821 PMC: 11817292. DOI: 10.3390/ijms26031056.


Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential.

Limbu K, Chhetri R, Kim S, Shrestha J, Oh Y, Baek D Cancer Cell Int. 2024; 24(1):353.

PMID: 39462385 PMC: 11514880. DOI: 10.1186/s12935-024-03535-7.


Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.

Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.

PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.

References
1.
Olivera A, Spiegel S . Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature. 1993; 365(6446):557-60. DOI: 10.1038/365557a0. View

2.
Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y . Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol. 2003; 23(5):1534-45. PMC: 151702. DOI: 10.1128/MCB.23.5.1534-1545.2003. View

3.
Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S . Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 1999; 147(3):545-58. PMC: 2151183. DOI: 10.1083/jcb.147.3.545. View

4.
Rittling S . Clonal nature of spontaneously immortalized 3T3 cells. Exp Cell Res. 1996; 229(1):7-13. DOI: 10.1006/excr.1996.0337. View

5.
Talmont F, Hatzoglou A, Cuvillier O . [Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors]. Med Sci (Paris). 2020; 36(3):243-252. DOI: 10.1051/medsci/2020026. View